GBI Research
Asia-Pacific flu market to hit $1.71bn by 2022
January 20, 2017Business Services, Medical Communications APAC, GBI Research
According to new data from intelligence provider GBI Research, the flu vaccines market in the Asia-Pacific (APAC) region is set …
Neurodegenerative market to be worth $45 billion by 2022
December 12, 2016Sales and Marketing Biogen, GBI Research, Novartis, Roche, Sanofi, neurodegenerative
Neurodegenerative disorders including Alzheimer’s, Parkinson’s, Huntington’s, amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS) form a lucrative worldwide market which …
OTC drugs market boosted by growing patient demand
December 24, 2015Manufacturing and Production, Sales and Marketing GBI Research, OTC, generics, over the counter
Increasing pressures from customers, drug manufacturers and regulators to convert prescription medications to over-the-counter (OTC) non-prescription status is driving growth …
Lung cancer market to hit $10.9bn by 2021
September 10, 2015Sales and Marketing AZD9291, GBI Research, GlobalData, NSCLC, industry analysis, industry intelligence, industry reports, keytruda, market intelligence lung cancer, market reports, market trends, non small cell lung cancer, non-small cell lung cancer, opdivo, world conference on lung cancer
The global market value for non-small cell lung cancer treatment will rise from $6.9 billion in 2014 to $10.9 billion …
